青少年和年轻成人淋巴瘤患者的肿瘤侵袭性与卵巢刺激结局之间是否存在关系?
该回顾性分析纳入2012至2021年间法国里尔大学医院77例新诊断霍奇金淋巴瘤的未化疗女性,共78个卵巢刺激周期,比较早期/中期(GHSG I+II)与晚期(GHSG III)患者的卵母细胞队列,主要终点为获取的MII卵母细胞数。调整BMI、年龄、预处理AMH及促性腺激素总剂量后,GHSG分期对MII卵母细胞数无显著影响(相对风险0.96,95%CI 0.68-1.34;P=0.79),Hasenclever评分亦无显著关联。结论认为肿瘤侵袭性对MII卵母细胞数无显著影响,建议无论霍奇金病分期均应系统性地提出生育力保存。
要点
- GHSG分期对获取的MII卵母细胞数无显著影响(相对风险0.96,95%CI 0.68-1.34;P=0.79)。
- Hasenclever评分与获取的MII卵母细胞数无显著关联。
- 作者认为无论霍奇金病分期,年轻女性均应系统性地提出生育力保存。
核心结论
- 肿瘤侵袭性对年轻霍奇金淋巴瘤女性获取的MII卵母细胞数未发现显著影响。
- 这些结果提示,无论霍奇金病分期,年轻女性均应系统性地提出生育力保存。
研究设计与样本
- 回顾性分析前瞻性收集的数据。
- 2012至2021年间在法国里尔大学医院生育力保存观察中心前瞻性入组77例新诊断霍奇金淋巴瘤的未化疗女性,共进行78个卵巢刺激周期。
- 比较早期和中期疾病[德国霍奇金研究组(GHSG)I+II]与晚期疾病(GHSG III)患者的卵母细胞队列特征,并在GHSG III患者中分析Hasenclever评分对生育力保存结局的影响。
- 主要终点为获取的MII卵母细胞数。
主要发现
- 除体重指数(BMI)外,各组具有可比性。
- 总体获取的MII卵母细胞数中位数为7个(四分位距4-11)。
- 在调整BMI、年龄、预处理抗苗勒管激素浓度及促性腺激素总剂量前后,GHSG状态对获取的MII卵母细胞数无显著影响(相对风险0.96,95%CI 0.68-1.34;P=0.79),对其他卵巢刺激结局亦无显著影响。
- Hasenclever评分与获取的MII卵母细胞数无显著关联。
临床怎么用
- 作者认为,无论霍奇金病分期,年轻女性均应系统性地提出生育力保存。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does the aggressiveness of Hodgkin lymphoma impact the oocyte cohort after ovarian stimulation for fertility preservation? DESIGN: A retrospective analysis of prospectively collected data was undertaken. Seventy-seven chemo-naive women with newly diagnosed Hodgkin lymphoma were enrolled prospectively at the Observatory and Fertility Preservation Centre, Lille University Hospital, France between 2012 and 2021. Seventy-eight ovarian stimulation cycles were performed. Oocyte cohort characteristics were compared between patients with early and intermediate stage disease [German Hodgkin Study Group (GHSG) I + II] and patients with advanced stage disease (GHSG III). Among the GHSG III patients, the influence of the Hasenclever score on fertility preservation outcomes was analysed. The primary endpoint was the number of metaphase II oocytes (MII) retrieved. RESULTS: The groups were comparable except for body mass index (BMI). Overall, a median of seven (interquartile range 4-11) MII oocytes were retrieved. Before and after adjustment for BMI, age, pre-treatment anti-Müllerian hormone concentration, and total dose of gonadotrophin, GHSG status did not have a significant impact on the number of MII oocytes retrieved [relative risk 0.96, 95% confidence interval 0.68-1.34; P = 0.79] or the other ovarian stimulation outcomes. The Hasenclever score was not significantly associated with the number of MII oocytes retrieved. CONCLUSION: Tumour aggressiveness was not found to have a significant influence on the number of MII oocytes retrieved in young women with Hodgkin lymphoma. These results suggest that fertility preservation should be proposed systematically, regardless of the stage of Hodgkin disease, in young women.
引用
- Simon V, Chuzel C, Behal H, et al. Is there a relationship between tumour aggressiveness and ovarian stimulation outcomes in adolescent and young adult patients with lymphoma? Reprod Biomed Online. 2024. PMID: 39827754. doi:10.1016/j.rbmo.2024.104448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。